Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...

A study found neurofilament light chain at high levels in the blood and CSF of MS patients, suggesting its potential as a ...

Switching from one CD20-targeting therapy to another doesn't alter their ability to lower disease activity and slow disability progression.

Columnist Ben Hofmeister says he makes sure to ask questions in a healthcare setting because his experience as a patient is important.

Susan Payrovi, MD, and Mirla Avila, MD, discuss early gut microbiome formation and its lifelong influence on MS and immune ...

Columnist Desiree Lama describes her unexpected joy at having a new cat join her existing feline friend, especially when they ...

Medications that promote repair of the myelin sheath that protects nerve cells may help limit damage due to MS, a trial ...

Women in their childbearing years are significantly less likely than men in the same age range to be given disease-modifying ...

Columnist Susan Payrovi, MD, discusses the importance of prioritizing play. For her, it's a key source of physical and mental ...

Three prevalent symptoms in MS – fatigue, mobility and cognitive impairment – generally aren't barriers to healthy habits, a ...

The effort to explore the genetic link between the Epstein-Barr virus and the risk of developing MS was awarded a $24,400 ...

Using an estrogen hormone like estradiol may help reduce inflammation and nerve damage in progressive forms of MS, a study in ...